arrow_back Back to App

Drug Price Transparency Act: Ending Hidden Rebates

This act aims to increase transparency in prescription drug prices. It introduces changes that will make discounts from drug manufacturers visible to patients at the point of sale, potentially lowering drug costs. These changes apply to both insurance programs and private health plans.
Key points
Drug manufacturer discounts must be reflected at the point of sale to the patient, potentially reducing drug prices.
Pharmacy benefit managers (PBMs) will only be able to receive flat service fees from drug manufacturers, which must be transparent to health plans.
The new rules will take effect on January 1, 2023, covering Medicare programs, private insurance, and employee plans.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_1523
Sponsor: Sen. Braun, Mike [R-IN]
Process start date: 2021-04-29
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Drug Price Transparency Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_1523.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-04-29.

What are the main provisions?

Key points include:

  • Drug manufacturer discounts must be reflected at the point of sale to the patient, potentially reducing drug prices.
  • Pharmacy benefit managers (PBMs) will only be able to receive flat service fees from drug manufacturers, which must be transparent to health plans.
  • The new rules will take effect on January 1, 2023, covering Medicare programs, private insurance, and employee plans.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Braun, Mike [R-IN].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health